Order Article Reprints

Tarin M, Némati F, Decaudin D, Canbezdi C, Marande B, Silva L, Derrien H, Jochemsen AG, Gardrat S, Piperno-Neumann S, et al. FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma. Cancers. 2023; 15(8):2280. https://doi.org/10.3390/cancers15082280

Tarin, Malcy, Fariba Némati, Didier Decaudin, Christine Canbezdi, Benjamin Marande, Lisseth Silva, Héloïse Derrien, Aart G. Jochemsen, Sophie Gardrat, Sophie Piperno-Neumann, and et al. 2023. "FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma" Cancers 15, no. 8: 2280. https://doi.org/10.3390/cancers15082280

Tarin, M., Némati, F., Decaudin, D., Canbezdi, C., Marande, B., Silva, L., Derrien, H., Jochemsen, A. G., Gardrat, S., Piperno-Neumann, S., Rodrigues, M., Mariani, P., Cassoux, N., Stern, M.-H., Roman-Roman, S., & Alsafadi, S. (2023). FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma. Cancers, 15(8), 2280. https://doi.org/10.3390/cancers15082280